
Retia, based in East Lansing, Michigan, develops precise cardiovascular monitoring software and hardware.
Retia Medical, founded in East Lansing, Michigan, is dedicated to developing precise cardiovascular monitoring software and hardware. Their core mission is to enhance patient care by providing accurate and reliable cardiac output (CO) measurements, especially for patients experiencing shock. Retia's products are designed for use in various clinical settings, including ICUs and high-risk medical scenarios such as sepsis, transplants, and COVID-19 cases.
Notable affiliated individuals and investors in Retia Medical include key figures from the medical technology industry, though specific names are not provided. The company has achieved significant milestones in demonstrating the value and accuracy of their monitoring systems through clinical case studies. Retia's impact is evident in its contribution to improving patient outcomes and advancing cardiovascular monitoring technology.

Vital Metrix

Atrility Medical
atrility.com

CoraVie Medical
coraviemedical.com

Renata Medical
renatamedical.com

ReliantHeart
reliantheart.com

Retrieve Medical
Impedance Cardiology Systems

InvisionHeart
invisionheart.com

Caretaker Medical

Reprieve Cardiovascular
reprievecardio.com
Vasoptic Medical

MiRTLE Medical
mirtlemed.com

Ambient Clinical Analytics

Innovative Cardiovascular Solutions
emblok.com

ReThink Medical

Vixiar Medical
vixiar.com

410 Medical
410medical.com

Optain
optainhealth.com

Solinas Medical
solinasmedical.com

Contego Medical
contegomedical.com
Companies similar to Retia Medical include Vital Metrix, Atrility Medical, CoraVie Medical and Renata Medical.
Retia Medical was founded in 2011.
Retia Medical's headquarters is located in East Lansing, MI, US.
Retia Medical's most recent funding round was for $15M (USD) in July 2022.
As of Jul 18, 2022, Retia Medical has disclosed funding of $22M (USD).
Retia Medical has 38 employees as of Feb 5, 2024.